On September 28, Regeneron Pharmaceuticals fell 3.52% in regular trading, trading at $760.15 USD/share, with Turnover of $56.72 million.

Within the Biotechnology sector where Regeneron Pharmaceuticals belongs, the sector showed mixed performance. Among individual stocks, Kodiak Sciences Inc. up 140.17%, Lakewood-Amedex Biotherapeutics up 3.59%, Amgen up 0.54%, Gilead Sciences down 0.50%, Moderna, Inc. down 4.16%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)